NanoViricides, Inc., a clinical stage nano-biopharmaceutical company, discovers, develops, and commercializes drugs to combat viral infections. The company's product portfolio includes NV-387 drug candidate developed for RSV and influenza indications and has completed phase 1a/1b human clinical...
54 insider purchases on record · latest filing 2015-11-17.
Insiders have also filed 11 sale transactions at NNVC.